Immuno Oncology Assays Market Size & Share, By Product (Consumables, Software and Services), Technology (Polymerase Chain Reaction (PCR), Flow Cytometry), Indication (Lung Cancer, Breast Cancer), Application (Research Applications, Clinical Diagnostics) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 3246| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Immuno Oncology Assays Market size is set to increase from USD 3.84 billion in 2024 to USD 6.62 billion by 2034, with a projected CAGR exceeding 5.6% from 2025 to 2034. The industry revenue for 2025 is anticipated to hit USD 4.03 billion.

Base Year Value (2024)
USD 3.84 billion
CAGR (2025-2034)
5.6%
Forecast Year Value (2034)
USD 6.62 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Immuno Oncology Assays Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: 1. Increasing prevalence of cancer: The rising incidence of various types of cancer globally is a major growth driver for the immuno-oncology assays market. According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, with approximately 9.6 million deaths in 2018. This growing burden of cancer is driving the demand for immuno-oncology assays for early detection, diagnosis, and treatment monitoring. 2. Technological advancements in immuno-oncology assays: The continuous advancements in technology have led to the development of more sensitive and specific immuno-oncology assays. This has significantly improved the accuracy and efficiency of cancer diagnosis and treatment monitoring, thereby driving the market growth. Additionally, the integration of novel techniques such as next-generation sequencing and multiplex assays has further boosted the demand for immuno-oncology assays. 3. Increasing investments in research and development: The increasing investments in R&D activities by pharmaceutical and biotechnology companies, as well as government organizations, are contributing to the growth of the immuno-oncology assays market. These investments are aimed at developing innovative assays and diagnostic tools for improved cancer diagnosis and treatment, which is expected to create lucrative opportunities for market growth. 4. Growing adoption of personalized medicine: The shift towards personalized medicine in cancer treatment, which involves the use of immuno-oncology assays for patient stratification and treatment selection, is fuelling market growth. Immuno-oncology assays play a crucial role in identifying biomarkers and predicting response to immunotherapy, thereby aiding in the development of targeted and personalized treatment approaches. Industry Restraints: 1. High cost of immuno-oncology assays: The high cost associated with immuno-oncology assays is a major restraint for market growth. The complex and specialized nature of these assays, coupled with the need for advanced equipment and skilled personnel, make them expensive, thereby limiting their adoption, particularly in developing regions. 2. Stringent regulatory requirements: The stringent regulatory approval process for immuno-oncology assays, particularly in developed countries, poses a significant challenge for market players. The lengthy and rigorous regulatory processes often result in delays in product commercialization, thereby affecting market growth. 3. Lack of awareness and infrastructure in developing regions: The lack of awareness about immuno-oncology assays and their benefits, coupled with inadequate healthcare infrastructure in developing regions, poses a challenge for market growth. Limited access to advanced diagnostic technologies and skilled personnel further hinders the adoption of immuno-oncology assays in these regions.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Immuno Oncology Assays Market
Largest Region
North America
XX% CAGR through 2034
North America: The Immuno Oncology Assays Market in North America is expected to witness substantial growth due to the increasing prevalence of cancer and the growing demand for personalized medicine. The U.S. is anticipated to lead the market in this region, driven by the presence of a well-established healthcare infrastructure and the rising adoption of advanced immuno-oncology assays. Canada is also expected to contribute significantly to the market growth, owing to the increasing investments in R&D activities and the expanding focus on developing innovative immuno-oncology assays. Asia Pacific: The Immuno Oncology Assays Market in Asia Pacific is poised for considerable growth, primarily propelled by the rising incidence of cancer and the growing focus on early diagnosis and treatment. China is expected to be a major market for immuno-oncology assays in this region, driven by the increasing government initiatives and the expanding healthcare expenditure. Japan is also projected to witness significant growth in the immuno-oncology assays market, supported by the presence of a large patient pool and the rising awareness about the benefits of immunotherapy in cancer treatment. South Korea is also expected to contribute to the market growth, attributable to the increasing investments in the development of advanced immuno-oncology assays. Europe: The Immuno Oncology Assays Market in Europe is anticipated to experience substantial growth, owing to the rising prevalence of cancer and the increasing focus on precision medicine. The United Kingdom is expected to lead the market in this region, driven by the expanding research activities and the growing adoption of immuno-oncology assays for cancer diagnosis and treatment. Germany is also projected to be a significant contributor to the market growth, supported by the presence of key market players and the increasing demand for advanced immuno-oncology assays. France is expected to witness notable growth in the immuno-oncology assays market, owing to the rising healthcare expenditure and the growing emphasis on personalized cancer therapy.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Immuno Oncology Assays Market Segment Analysis Product In the immuno oncology assays market, product segmentation refers to the different types of assays and kits available for analyzing the immune response in cancer. This includes immune checkpoint assays, tumor mutational burden assays, and cytokine profiling assays, among others. Each product serves a unique purpose in evaluating the interaction between the immune system and cancer cells, and the demand for these products is driven by the increasing focus on immunotherapy in cancer treatment. Technology The technology segment of the immuno oncology assays market involves the different methods and platforms used for conducting immuno oncology assays. This includes flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and immunohistochemistry (IHC), among others. The choice of technology can significantly impact the accuracy and efficiency of the assays, and the market for these technologies is driven by the need for advanced and sensitive methods for analyzing immune responses in cancer. Indication In the immuno oncology assays market, indication segmentation refers to the different types of cancer for which these assays are used. This includes breast cancer, lung cancer, melanoma, and other solid tumors, as well as blood cancers such as leukemia and lymphoma. Each type of cancer presents unique challenges in understanding the immune response, and the demand for immuno oncology assays varies based on the prevalence and complexity of different cancer indications. Application The application segment of the immuno oncology assays market involves the different uses of these assays in research, diagnosis, and drug development. Research applications include understanding the mechanisms of immune evasion in cancer, while diagnostic applications involve predicting response to immunotherapy. In drug development, these assays are used for patient stratification and monitoring treatment efficacy. The market for immuno oncology assays is shaped by the growing emphasis on personalized cancer treatment and the need for precise and reliable analysis of the immune response in oncology.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The competitive landscape in the Immuno Oncology Assays Market is characterized by intense rivalry among key players striving to gain a competitive edge through various strategic initiatives such as product launches, partnerships, and acquisitions. Companies are continuously focusing on developing innovative immuno oncology assays to enhance their market presence and expand their customer base. The market is witnessing a significant demand for immuno oncology assays due to the rising prevalence of cancer and the increasing focus on personalized medicine. Additionally, the growing investments in research and development activities are further fueling the competition in the market. Top Market Players: 1. Thermo Fisher Scientific Inc. 2. F. Hoffmann-La Roche Ltd. 3. Abbott Laboratories 4. Agilent Technologies, Inc. 5. Illumina, Inc. 6. Merck KGaA 7. PerkinElmer, Inc. 8. Sartorius AG 9. Bio-Rad Laboratories, Inc. 10. QIAGEN N.V.
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Immuno Oncology Assays Market — Custom Segments

Segment Sub-Segment
No segment data available.

Immuno Oncology Assays Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →